Mr Mark Buick1, Nicola Tsang2, Dr Andrew Berry2
1Total Aerospace Solutions Pty Ltd, 2NETS NSW
This presentation explains the purpose of inhaled Nitric Oxide (iNO) as a treatment and explores testing and assessments conducted to underpin the approval for use in both rotary and fixed wing aircraft, taking into account therapeutic, patient care and safety issues.
The presentation will address;
1) Clinical background
– Indications for the treatment
– Target patient group
– Decision-making process
– Mechanism of action
– Other treatments likely to be in use
2) Airworthiness approval including;
– Summary of gas toxicity safety factors
– Nitric Oxide delivery certification basis
– Safety of flight considerations
– Risk mitigation
Biography:
Nicola Tsang
I have a dual role working for the NSW Newborn and paediatric Emergency Transport Service (NETS), 0.5 as a clinical nurse educator and 0.5 as the acting nurse educator. I have been with NETS for the last 12 years, and was a clinical nurse specialist at the children’s intensive care unit at Sydney Children’s Hospital Randwick for 6 years prior to NETS. Nursing was my 2nd career, I was a fabric technologist before going into nursing in my late 20s. From very early in my nursing career I knew I wanted to work in paediatrics and to work at NETS. I love the diversity and dynamic work environment that NETS provides. Most of all I feel privileged to meet the patients and their families, to see their bravery at the worst time in their lives with the hope that I may have played a small part in making a positive difference in their life, no matter how short or long.